Dr. Matthew Blake Lockwood, MD

In 2023, among providers in related specialties within Arkansas, Dr. Matthew Blake Lockwood, MD performed more lab tests, phosphorus blood test, and total PSA test procedures for Medicare patients than 95% of them and he also had a list price for amylase test, antineoplastic hormone therapy, CA-125 test, cancer antigen tests, cardiac imaging, chronic care, color Doppler echocardiography, C-reactive protein testing, Doppler echocardiography, echocardiogram (echo), gamma-glutamyl transferase (GGT) test, hormone replacement therapy, hormone therapy, limited abdominal ultrasound, lipase test, pelvic MRI, port flush, spectral Doppler echocardiography, spine MRI, testosterone injections, testosterone therapy, therapeutic phlebotomy, and transthoracic echocardiography (TTE) that was lower than the list prices billed to Medicare by 95% of them. Actual amounts paid by patients can vary widely depending on a number of factors, including insurance coverage. A lower list price, however, might mean lower fees when paying without insurance.

In 2023, among providers in related specialties within Arkansas, Dr. Matthew Blake Lockwood, MD performed more testosterone injections, and uric acid blood test procedures for Medicare patients than 90% of them and he also had a list price for brain MRI, MRI (magnetic resonance imaging), and neck CT scan that was lower than the list prices billed to Medicare by 90% of them. Actual amounts paid by patients can vary widely depending on a number of factors, including insurance coverage. A lower list price, however, might mean lower fees when paying without insurance.

In 2013, among providers in related specialties within Arkansas, Dr. Matthew Blake Lockwood, MD performed more biological response modifier (BRM) therapy, complete blood count (CBC), inpatient hospital care (for patient admitted to hospital), intravenous (IV) chemotherapy, intravenous (IV) infusion, and urinalysis procedures for Medicare patients than 75% of them and he also had a list price for abdominal MRI, bilirubin test, intravenous infusion therapy, and intravenous (IV) infusion that was lower than the list prices billed to Medicare by 75% of them. Actual amounts paid by patients can vary widely depending on a number of factors, including insurance coverage. A lower list price, however, might mean lower fees when paying without insurance.